Clinical trial
A Pilot Study of EM-1421 for the Treatment of Cervical Intraepithelial Neoplasia
NCT00154089 · Erimos Pharmaceuticals, Industry · Completed
Key facts
| NCT number | NCT00154089 |
|---|---|
| Title | A Pilot Study of EM-1421 for the Treatment of Cervical Intraepithelial Neoplasia |
| Official title | A Pilot Translational Study of Tetra-O-Methyl Nordihydroguaiaretic Acid (EM-1421) for the Treatment of Cervical Intraepithelial Neoplasia Induced by Human Papilloma Virus |
| Lead sponsor | Erimos Pharmaceuticals, Industry |
| Collaborators | University of Maryland, Baltimore County Planned Parenthood Delaware (Wilmington, DE) |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Cervical Intraepithelial Neoplasia |
| Intervention type | Drug |
| Interventions | EM-1421 |
| Enrollment | 8 |
| Start date | Nov 1, 2004 |
| Primary completion | Apr 1, 2006 |
| Completion | Dec 1, 2006 |
| First posted | Sep 12, 2005 |
| Last update posted | Feb 23, 2016 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: